GSK's Hibsago won FDA approval as a potential functional cure for hepatitis B, but a black box warning could limit its appeal.
endpoints.newsGSK gets FDA approval for hepatitis B drug that offers functional cureFDA approves GSK and Ionis’ hepatitis B drug Hibsago early, but a boxed warning and weekly lab monitoring could slow uptake.
0 reposts0 likes